Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 170,638 | 4,675 | 4,167 | 254,953 | 0 |
| Gross Profit | 170,638 | 4,675 | 4,167 | 254,953 | N/A |
| Operating Expenses | 43,858 | 46,128 | 42,960 | 48,644 | 36,951 |
| Operating Income | 126,780 | -41,453 | -38,793 | 206,309 | 23,049 |
| Other Income | 6,884 | 7,823 | 7,501 | 4,357 | 4,286 |
| Pre-tax Income | 133,664 | -33,630 | -31,292 | 210,666 | 27,335 |
| Income Tax | 1,990 | -420 | -676 | 3,326 | N/A |
| Net Income Continuous | 131,674 | -33,210 | -30,616 | 207,340 | 27,335 |
| Net Income | $131,674 | $-33,210 | $-30,616 | $207,340 | $27,335 |
| EPS Basic Total Ops | 2.10 | -0.54 | -0.50 | 3.41 | 0.54 |
| EPS Basic Continuous Ops | 2.10 | -0.54 | -0.50 | 3.41 | 0.53 |
| EPS Diluted Total Ops | 2.01 | -0.54 | -0.50 | 3.26 | 0.54 |
| EPS Diluted Continuous Ops | 2.01 | -0.54 | -0.50 | 3.26 | 0.53 |
| EPS Diluted Before Non-Recurring Items | 1.98 | -0.54 | -0.50 | N/A | N/A |
| EBITDA(a) | $124,556 | $-42,409 | $-40,798 | $205,514 | $-37,467 |